Skip to main content
logo
Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.450
-0.030 (-2.03%)
At close: Apr 6, 2026, 4:00 PM EDT
1.431
-0.019 (-1.29%)
After-hours: Apr 6, 2026, 5:51 PM EDT

Pyxis Oncology Revenue

In the year 2025, Pyxis Oncology had annual revenue of $13.86M, down -14.17%. Pyxis Oncology had revenue of $11.04M in the quarter ending December 31, 2025.

Revenue (ttm)
$13.86M
Revenue Growth
-14.17%
P/S Ratio
6.76
Revenue / Employee
$247,464
Employees
56
Market Cap
91.11M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202513.86M-2.29M-14.17%
Dec 31, 202416.15M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Q32 Bio53.74M
Verrica Pharmaceuticals35.58M
Seer, Inc.16.58M
Coya Therapeutics7.95M
Seres Therapeutics789.00K
Spruce Biosciences697.00K
Revenue Rankings

PYXS News

More News